334 related articles for article (PubMed ID: 35243749)
1. Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI.
Jiang H; Wei J; Fu F; Wei H; Qin Y; Duan T; Chen W; Xie K; Lee JM; Bashir MR; Wang M; Song B; Tian J
Liver Int; 2022 May; 42(5):1158-1172. PubMed ID: 35243749
[TBL] [Abstract][Full Text] [Related]
2. Extracellular contrast agent-enhanced MRI is as effective as gadoxetate disodium-enhanced MRI for predicting microvascular invasion in HCC.
Sheng L; Wei H; Yang T; Yang J; Zhang L; Zhu X; Jiang H; Song B
Eur J Radiol; 2024 Jan; 170():111200. PubMed ID: 37995512
[TBL] [Abstract][Full Text] [Related]
3. VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC.
Jiang H; Wei H; Yang T; Qin Y; Wu Y; Chen W; Shi Y; Ronot M; Bashir MR; Song B
Radiology; 2023 Apr; 307(2):e221835. PubMed ID: 36786702
[TBL] [Abstract][Full Text] [Related]
4. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm.
Chong HH; Yang L; Sheng RF; Yu YL; Wu DJ; Rao SX; Yang C; Zeng MS
Eur Radiol; 2021 Jul; 31(7):4824-4838. PubMed ID: 33447861
[TBL] [Abstract][Full Text] [Related]
5. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
6. A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria.
Ryu T; Takami Y; Wada Y; Tateishi M; Hara T; Yoshitomi M; Momosaki S; Yasumori K; Saitsu H; Okuda K
J Gastrointest Surg; 2019 Apr; 23(4):779-787. PubMed ID: 30788712
[TBL] [Abstract][Full Text] [Related]
7. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
[TBL] [Abstract][Full Text] [Related]
8. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
Cha DI; Kang TW; Jeong WK; Kim JM; Choi GS; Joh JW; Yi NJ; Ahn SH
Eur Radiol; 2024 Jan; 34(1):498-508. PubMed ID: 37505248
[TBL] [Abstract][Full Text] [Related]
9. Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging.
Chen Y; Qin Y; Wu Y; Wei H; Wei Y; Zhang Z; Duan T; Jiang H; Song B
Front Immunol; 2022; 13():973153. PubMed ID: 36091074
[TBL] [Abstract][Full Text] [Related]
10. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma.
Lee S; Kim SH; Lee JE; Sinn DH; Park CK
J Hepatol; 2017 Sep; 67(3):526-534. PubMed ID: 28483680
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
Chen Y; Xia Y; Tolat PP; Long L; Jiang Z; Huang Z; Tang Q
AJR Am J Roentgenol; 2021 Jun; 216(6):1510-1520. PubMed ID: 33826360
[No Abstract] [Full Text] [Related]
12. Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images.
Kim KA; Kim MJ; Jeon HM; Kim KS; Choi JS; Ahn SH; Cha SJ; Chung YE
J Magn Reson Imaging; 2012 Mar; 35(3):629-34. PubMed ID: 22069244
[TBL] [Abstract][Full Text] [Related]
13. Comparison of non-radiomics imaging features and radiomics models based on contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma within 5 cm.
Zheng R; Zhang X; Liu B; Zhang Y; Shen H; Xie X; Li S; Huang G
Eur Radiol; 2023 Sep; 33(9):6462-6472. PubMed ID: 37338553
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of imaging features in the HBP of gadoxetate disodium-enhanced MRI for microvascular invasion in hepatocellular carcinoma: a meta-analysis.
Deng Y; Yang D; Xu H; Ren A; Yang Z
Acta Radiol; 2022 Oct; 63(10):1303-1314. PubMed ID: 34459669
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for Predicting Microvascular Invasion in Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced MRI and Intravoxel Incoherent Motion Imaging.
Zhou L; Qu Y; Quan G; Zuo H; Liu M
Acad Radiol; 2024 Feb; 31(2):457-466. PubMed ID: 37491178
[TBL] [Abstract][Full Text] [Related]
16. Deep-learning-based analysis of preoperative MRI predicts microvascular invasion and outcome in hepatocellular carcinoma.
Sun BY; Gu PY; Guan RY; Zhou C; Lu JW; Yang ZF; Pan C; Zhou PY; Zhu YP; Li JR; Wang ZT; Gao SS; Gan W; Yi Y; Luo Y; Qiu SJ
World J Surg Oncol; 2022 Jun; 20(1):189. PubMed ID: 35676669
[TBL] [Abstract][Full Text] [Related]
17. Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
Min JH; Lee MW; Park HS; Lee DH; Park HJ; Lim S; Choi SY; Lee J; Lee JE; Ha SY; Cha DI; Carriere KC; Ahn JH
Radiology; 2020 Dec; 297(3):573-581. PubMed ID: 32990512
[TBL] [Abstract][Full Text] [Related]
18. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
19. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.
Xu X; Zhang HL; Liu QP; Sun SW; Zhang J; Zhu FP; Yang G; Yan X; Zhang YD; Liu XS
J Hepatol; 2019 Jun; 70(6):1133-1144. PubMed ID: 30876945
[TBL] [Abstract][Full Text] [Related]
20. Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: An intra-individual comparative study based on the Liver Imaging Reporting and Data System.
Yang J; Jiang H; Xie K; Bashir MR; Wan H; Huang J; Qin Y; Chen J; Lu Q; Song B
Eur J Radiol; 2022 Sep; 154():110397. PubMed ID: 35696735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
